High Tower Advisors, LLC Amarin Corp Plcuk Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, High Tower Advisors, LLC holds 51,141 shares of AMRN stock, worth $27,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,141
Previous 21,041
143.05%
Holding current value
$27,104
Previous $13,000
84.62%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AMRN
# of Institutions
183Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$13.2 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$6.58 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.34 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.33 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.32 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $214M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...